We are live on ! Find out more
DA

Dillon & Associates Portfolio holdings

AUM $726M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+18.67%
1 Year Est. Return
+18.59%
3 Year Est. Return
+92.03%
5 Year Est. Return
+130.73%
10 Year Est. Return
+511.58%
AUM
$308M
AUM Growth
+$45.3M
Cap. Flow
-$155K
Cap. Flow %
-0.05%
Top 10 Hldgs %
45.02%
Holding
67
New
2
Increased
23
Reduced
27
Closed
1

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.48M
2
BDX icon
Becton Dickinson
BDX
+$1.25M
3
STZ icon
Constellation Brands
STZ
+$1.23M
4
EEFT icon
Euronet Worldwide
EEFT
+$627K
5
CRM icon
Salesforce
CRM
+$623K

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$4.89M
2
CL icon
Colgate-Palmolive
CL
+$879K
3
CTSH icon
Cognizant
CTSH
+$575K
4
CELG
Celgene Corp
CELG
+$302K
5
BMY icon
Bristol-Myers Squibb
BMY
+$213K

Sector Composition

Rank Sector Weight
1 Technology 23.18%
2 Healthcare 22.79%
3 Consumer Staples 9.86%
4 Financials 9.83%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WBA
51
DELISTED
Walgreens Boots Alliance
WBA
$577K 0.19%
9,157
– –
K
52
DELISTED
Kellanova
K
$480K 0.16%
8,967
– –
CSCO icon
53
Cisco
CSCO
$457B
$469K 0.15%
8,683
-225
-3% -$10.9K
KO icon
54
Coca-Cola
KO
$377B
$370K 0.12%
7,877
– –
ETN icon
55
Eaton
ETN
$161B
$354K 0.12%
4,366
– –
AMZN icon
56
Amazon
AMZN
$2.92T
$335K 0.11%
3,760
– –
XOM icon
57
ExxonMobil
XOM
$644B
$321K 0.1%
3,967
-629
-14% -$48K
EMR icon
58
Emerson Electric
EMR
$83.9B
$276K 0.09%
4,057
– –
ENB icon
59
Enbridge
ENB
$119B
$270K 0.09%
7,500
-4,375
-37% -$158K
MRK icon
60
Merck
MRK
$322B
$260K 0.08%
3,280
– –
TGT icon
61
Target
TGT
$65.6B
$234K 0.08%
+2,925
New +$214K
UNH icon
62
UnitedHealth
UNH
$376B
$222K 0.07%
900
– –
COP icon
63
ConocoPhillips
COP
$147B
$206K 0.07%
+3,070
New +$207K
BRK.B icon
64
Berkshire Hathaway Class B
BRK.B
$1.1T
$200K 0.07%
997
– –
IMNN icon
65
Imunon
IMNN
$6.68M
$45K 0.01%
114
+2
+2% +$829
GCVRZ
66
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$5K ﹤0.01%
10,260
– –
BMY icon
67
Bristol-Myers Squibb
BMY
$133B
– –
-4,090
Closed -$213K
1 2
3

Similar funds

TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
SCM
SKBA Capital Management San Francisco, California $728M AUM 12.18% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $729M AUM 15.61% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return

Dillon & Associates's Q1 2019 Portfolio in Review

As of Q1 2019, Dillon & Associates held 67 positions worth $308M, up 17% from $263M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Trading was light in Q1 2019: portfolio turnover was 4.5%. Dillon & Associates opened 2 new positions and exited 1, leaving the 67-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.

  • Dillon & Associates's largest Q1 2019 buy was Target: 2,925 shares worth $234K.
  • Dillon & Associates added most to NVIDIA in Q1 2019, an estimated $1.48M increase.
  • Dillon & Associates's biggest Q1 2019 reduction was AbbVie, cutting an estimated $4.89M.
  • Dillon & Associates fully exited Bristol-Myers Squibb in Q1 2019, selling an estimated $213K.
  • Dillon & Associates's ten largest holdings make up 45% of its $308M portfolio in Q1 2019.
  • Dillon & Associates opened 2 new positions and closed 1 in Q1 2019.
  • Dillon & Associates's portfolio value rose 17% quarter-over-quarter to $308M.

Based on Dillon & Associates's 13F filing for Q1 2019, filed 7 May 2019.